We are live on
!
Find out more
CA
Cortland Associates Portfolio holdings
AUM
$692M
1-Year Est. Return
5%
This Fund
S&P 500
This Quarter
Est. Return
+12.23%
1 Year Est. Return
-5%
3 Year Est. Return
+57.07%
5 Year Est. Return
+61.48%
10 Year Est. Return
+413.35%
AUM
$879M
AUM Growth
+$56.2M
(+6.8%)
Cap. Flow
-$26.9M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
65.53%
Holding
60
New
3
Increased
12
Reduced
28
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Advantage
FA
|
+$24.6M |
| 2 |
LB
LandBridge Co
LB
|
+$9.04M |
| 3 |
iShares S&P 100 ETF
OEF
|
+$200K |
| 4 |
Philip Morris
PM
|
+$18.2K |
| 5 |
Altria Group
MO
|
+$16.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Pacific Land
TPL
|
+$32.3M |
| 2 |
Cigna
CI
|
+$15.5M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$1.71M |
| 4 |
Booking.com
BKNG
|
+$1.42M |
| 5 |
Visa
V
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.32% |
| 2 | Technology | 17.65% |
| 3 | Consumer Discretionary | 15.58% |
| 4 | Healthcare | 8.84% |
| 5 | Communication Services | 8.26% |
Similar funds
CL
CPA
NMC
SSA
WC
CGIC
LCP
SAM
Cortland Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Cortland Associates held 60 positions worth $879M, up 6.8% from $823M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Cortland Associates withdrew a net $26.9M in Q4 2024, closing 1 position and reducing 28 holdings. Its most notable exit was Pfizer, an estimated $213K position sold in full.
By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cortland Associates opened a new position in First Advantage worth $24.3M.
- Cortland Associates's largest Q4 2024 buy was First Advantage: 1,298,855 shares worth $24.3M.
- Cortland Associates added most to Philip Morris in Q4 2024, an estimated $18.2K increase.
- Cortland Associates's biggest Q4 2024 reduction was Texas Pacific Land, cutting an estimated $32.3M.
- Cortland Associates fully exited Pfizer in Q4 2024, selling an estimated $213K.
- Cortland Associates's ten largest holdings make up 66% of its $879M portfolio in Q4 2024.
- Cortland Associates opened 3 new positions and closed 1 in Q4 2024.
- Cortland Associates's portfolio value rose 6.8% quarter-over-quarter to $879M.
Based on Cortland Associates's 13F filing for Q4 2024, filed 23 Jan 2025.